Recombinant human C1-inhibitor in the treatment of acute angioedema attacks
✍ Scribed by Goda Choi; Maarten R. Soeters; Henriette Farkas; Lilian Varga; Krystyna Obtulowicz; Barbara Bilo; Greg Porebski; C. Erik Hack; René Verdonk; Jan Nuijens; Marcel Levi
- Book ID
- 109143629
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 203 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Therapeutic application of the serpin C1-inhibitor (C1-Inh) in inflammatory diseases like sepsis, acute myocardial infarction and vascular leakage syndrome seems promising, but large doses may be required. Therefore, a high-yield recombinant expression system for C1-Inh is very interesting. Earlier
Hereditary angioedema (HAE) is due to a variety of defects in the C1 inhibitor gene (C1NH gene), including approximately 20% of partial deletions/duplications whose boundaries are usually within Alu repeats. To ensure complete molecular characterization of C1 inhibitor deficiencies a fluorescent mul